Prevention of abnormal scarring in woundhealing
S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention
of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
Alle Nachrichten aus der Kategorie: Technology Offerings
Neueste Beiträge
An artificial cell on a chip
Researchers at the University of Basel have developed a precisely controllable system for mimicking biochemical reaction cascades in cells. Using microfluidic technology, they produce miniature polymeric reaction containers equipped with…
Specific and rapid expansion of blood vessels
Nature Communications: KIT researchers identify a new mechanism to control endothelial cell size and arterial caliber – basis for better treatment of heart infarct and stroke. Upon a heart infarct…
Climate change drives plants to extinction in the Black Forest in Germany
Climate change is leaving its mark on the bog complexes of the German Black Forest. Due to rising temperatures and longer dry periods, two plant species have already gone extinct…